|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07H 21/00 | |
| C12N 15/11 | |||
| A61K 45/06 | |||
| A61K 31/282 | |||
| A61K 31/337 | |||
| A61K 31/4406 | |||
| A61K 31/7084 | |||
| A61K 33/24 |
| (11) | Number of the document | 2944646 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15161013.6 |
| Date of filing the European patent application | 2006-09-25 | |
| (97) | Date of publication of the European application | 2015-11-18 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-08 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 241799 | 2005-09-29 | US |
| (72) |
Phiasivongsa, Pasit, US
Redkar, Sanjeev, US
|
| (73) |
Astex Pharmaceuticals, Inc.,
4420 Rosewood Drive, Suite 200, Pleasanton, CA 94588,
US
|
| (54) | Oligonucleotide analogues incorporating 5-aza-cytosine therein |
| Oligonucleotide analogues incorporating 5-aza-cytosine therein |